- Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN2015 | First Faculty of Medicine
- Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial2016 | First Faculty of Medicine
- HIV resistance testing and detected drug resistance in Europe2015 | Third Faculty of Medicine